[Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)]
- PMID: 1070948
- DOI: 10.1007/BF00367455
[Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)]
Abstract
The study compares altered states of consciousness induced by the hallucinogens (--)delta9-trans-Tetrahydrocannabinol (delta9-THC) and N,N-Dimethyltryptamine (DMT) using two placebo control groups. A total of 24 subjects received 250 mug delta9-THC p.o./kg body weight and 26 subjects were treated with 250 mug DMT i.m./kg. Placebo was given to 24 subjects. The effects were assessed by a questionnaire administered following the experimental conditions. Questionnaire items were combined into the following eight scales according to their content and several cirteria of the theory of mental testing: visual hallucinations (illusions), auditory hallucinations (illusions), impairment of memory and attention, depersonalization syndrome, deprealization syndrome, changes of body image, euphoric state and anxious-depressive state. The two hallucinogen groups differed significantly from placebo on all eight scales. No difference, however, between delta9-THC and DMT was significant. On the scale "optical hallucinations (illusions)" a tendency that DMT might have stronger effects than delta9-THC was found. Methodological problems of comparing different hallucinogens are discussed.
Similar articles
-
[Altered states of consciousness induced by N,N-dimethyltryptamine (DMT)].Pharmakopsychiatr Neuropsychopharmakol. 1976 Sep;9(5):220-5. doi: 10.1055/s-0028-1094495. Pharmakopsychiatr Neuropsychopharmakol. 1976. PMID: 1069314 Clinical Trial. German.
-
[Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].Pharmakopsychiatr Neuropsychopharmakol. 1977 Jan;10(1):10-4. doi: 10.1055/s-0028-1094512. Pharmakopsychiatr Neuropsychopharmakol. 1977. PMID: 329291 Clinical Trial. German.
-
Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.Arch Gen Psychiatry. 1994 Feb;51(2):98-108. doi: 10.1001/archpsyc.1994.03950020022002. Arch Gen Psychiatry. 1994. PMID: 8297217 Clinical Trial.
-
Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).ACS Chem Neurosci. 2018 Oct 17;9(10):2344-2357. doi: 10.1021/acschemneuro.8b00101. Epub 2018 Jul 23. ACS Chem Neurosci. 2018. PMID: 30036036 Review.
-
New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.J Pharmacol Sci. 2004 Dec;96(4):362-6. doi: 10.1254/jphs.fmj04003x2. Epub 2004 Dec 10. J Pharmacol Sci. 2004. PMID: 15599103 Review.
Cited by
-
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.Front Psychiatry. 2024 Jan 11;14:1305796. doi: 10.3389/fpsyt.2023.1305796. eCollection 2023. Front Psychiatry. 2024. PMID: 38274414 Free PMC article.
-
A Systematic Review of Study Design and Placebo Controls in Psychedelic Research.Psychedelic Med (New Rochelle). 2024 Mar 12;2(1):15-24. doi: 10.1089/psymed.2023.0028. eCollection 2024 Mar. Psychedelic Med (New Rochelle). 2024. PMID: 40051762 Free PMC article. Review.
-
Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.Brain Sci. 2013 Nov 15;3(4):1483-553. doi: 10.3390/brainsci3041483. Brain Sci. 2013. PMID: 24961619 Free PMC article.
-
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.Cell Mol Life Sci. 2024 Sep 10;81(1):395. doi: 10.1007/s00018-024-05353-6. Cell Mol Life Sci. 2024. PMID: 39254764 Free PMC article. Review.